ERBB2 and inflammatory breast carcinoma: Neoadjuvant chemotherapy (NAC), which is defined as chemotherapy administered prior to surgery, is primarily used for patients with locally advanced or inflammatory breast cancer and is also considered in selected early-stage cases with high-risk tumor biology, such as human epidermal growth factor receptor 2 (HER2) enriched or triple-negative subtypes [5].